|
Feng Gao was the Director General of Biotech and Biopharmaceutical Institute at Tasly (Tianshili) pharmaceutical groups in China. At this position, he led more than a dozen biotech initiatives and managed technical aspect of China�s largest cell culture manufacturing facility. He is an expert in the biotech and biopharmaceutical industry including governmental regulations. His operational experience at biopharmaceutical facility is highly regarded in China. Dr. Gao earned his medical degree from Peking University Medical School and Ph.D. from Medical College of Ohio. He also received post-doctoral training from University of Michigan, and became a researcher in Columbia University thereafter. He is a visiting professor in the esteemed Nankai University at Tianjin, China. Dr. Gao published two dozens of peer reviewed scientific articles in outstanding international journals and filed five patents. He was granted five Investigation New Drug Applications and one Biologic License Application lately. | 